|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 9/00 | (2006.01) |
| A61K 38/14 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 1292612 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01934967.9 |
| Date of filing the European patent application | 2001-05-01 | |
| (97) | Date of publication of the European application | 2003-03-19 |
| (45) | Date of publication and mention of the grant of the patent | 2006-08-23 |
| (46) | Date of publication of the claims translation | 2006-12-27 |
| (86) | Number | PCT/US2001/013998 |
| Date | 2001-05-01 |
| (87) | Number | WO 2001/098328 |
| Date | 2001-12-27 |
| (30) | Number | Date | Country code |
| 213410 P | 2000-06-22 | US |
| (72) |
LEADBETTER, Michael, R., US
LINSELL, Martin, S., US
|
| (73) |
Theravance Biopharma Antibiotics IP, LLC,
901 Gateway Boulevard, South San Francisco, CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Glikopeptido fosfonato dariniai |
| GLYCOPEPTIDE PHOSPHONATE DERIVATIVES |
| Payment date | Validity (years) | Amount | |
| 2018-04-18 | 18 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-05-01 |